Neovascularization and oxidative stress in the progression of non-alcoholic steatohepatitis

被引:2
作者
Kitade, Mitsuteru [1 ]
Yoshiji, Hitoshi [1 ]
Kojima, Hideyuki [1 ]
Ikenaka, Yasuhide [1 ]
Noguchi, Ryuichi [1 ]
Kaji, Kosuke [1 ]
Yoshii, Junichi [1 ]
Yanase, Koji [1 ]
Namisaki, Tadashi [1 ]
Yamazaki, Masaharu [1 ]
Tsujimoto, Tatsuhiro [1 ]
Moriya, Kei [1 ]
Kawaratani, Hideto [1 ]
Akahane, Takemi [1 ]
Fukui, Hiroshi [1 ]
机构
[1] Nara Med Univ, Dept Internal Med 3, Nara 6348522, Japan
关键词
non-alcoholic steatohepatitis; liver fibrosis; angiogenesis; oxidative stress;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Reactive oxygen species (ROS) is known to play an important role in the pathogenesis of non-alcoholic steatohepatitis (NASH); however, as we previously reported, angiogenesis also plays a pivotal role in NASH progression the development of liver fibrosis and hepatocellular carcinoma - in rats. The aim of the current study was to elucidate the role of angiogenesis in the development of fibrosis in NASH. Twenty-six patients with NASH and I I with simple fatty liver (FL) disease were enrolled in the study and underwent clinicopathological examination. Immunohistochemical analysis of 4-hydroxy-2-noneal (4-HNE) and CD34 was employed for the detection of ROS and angiogenesis in the liver tissues, respectively. Both the NASH and FL samples displayed a marked staining of 4-HNE as compared to the healthy liver. Similar levels of 4-HNE were observed in NASH regardless of the grade of liver fibrosis. In sharp contrast, hepatic neovascularization developed significantly in NASH alone, whereas almost no neovascularization was observed in FL or the healthy liver. The degree of angiogenesis was almost parallel with the development of liver fibrosis. In conclusion, simple FL and NASH cases were both affected by ROS. However, only NASH was associated with marked neovascularization, proportional to the increase in the grade of liver fibrosis development. These results indicate that hepatic neovascularization may play an important role in the onset and progression of NASH.
引用
收藏
页码:543 / 548
页数:6
相关论文
共 50 条
  • [41] Single-Cell Data Analysis Reveals Critical Hepatic Cells Subpopulations in the Progression of Non-alcoholic Fatty Liver Disease to Non-Alcoholic Steatohepatitis
    Zhao, Cuijuan
    Ji, Guixian
    Zhao, Xingliang
    Ma, Tengqi
    Li, Yanhua
    Wu, Wenbo
    Zhou, Lu
    COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2024,
  • [42] Sarcopenia in Non-alcoholic Steatohepatitis (NASH)
    Liu C.-H.
    Habig G.
    Smaltz C.
    Halegoua-DeMarzio D.
    Current Hepatology Reports, 2021, 20 (4) : 117 - 127
  • [43] Pharmacologic Therapy of Non-Alcoholic Steatohepatitis
    Ratziu, Vlad
    Zelber-Sagi, Shira
    CLINICS IN LIVER DISEASE, 2009, 13 (04) : 667 - +
  • [44] Liver fibrogenesis in non-alcoholic steatohepatitis
    Bian, Zhaolian
    Ma, Xiong
    FRONTIERS IN PHYSIOLOGY, 2012, 3
  • [45] Regulation of transglutaminase-mediated hepatic cell death in alcoholic steatohepatitis and non-alcoholic steatohepatitis
    Kojima, Soichi
    Kuo, Ting-Fang
    Tatsukawa, Hideki
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 : 52 - 57
  • [46] Therapeutic approaches for non-alcoholic steatohepatitis
    Van Gaal, Luc F.
    Mertens, Jonathan
    Francque, Sven
    De Block, Christophe
    THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2021, 12
  • [47] Emerging drugs for non-alcoholic steatohepatitis
    Tomeno, Wataru
    Yoneda, Masato
    Imajo, Kento
    Ogawa, Yuji
    Kessoku, Takaomi
    Saito, Satoru
    Eguchi, Yuichiro
    Nakajima, Atsushi
    EXPERT OPINION ON EMERGING DRUGS, 2013, 18 (03) : 279 - 290
  • [48] CEUS and Fibroscan in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
    Sila Cocciolillo
    Giustino Parruti
    Leonardo Marzio
    World Journal of Hepatology, 2014, (07) : 496 - 503
  • [49] Lifestyle Modifications in Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis
    Stavropoulos, Konstantinos
    Imprialos, Konstantinos
    Pittaras, Andreas
    Faselis, Charles
    Narayan, Puneet
    Kokkinos, Peter
    CURRENT VASCULAR PHARMACOLOGY, 2018, 16 (03) : 239 - 245
  • [50] Difference and similarity between non-alcoholic steatohepatitis and alcoholic liver disease
    Kojima, H
    Sakurai, S
    Uemura, M
    Takekawa, T
    Morimoto, H
    Tamagawa, Y
    Fukui, H
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2005, 29 (12) : 259S - 263S